SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the ...
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of ...
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other ...
Anxiety is best managed when the brain becomes less reactive to threats. Benzodiazepines can interfere with the learning ...
The number of things that can impact a person’s mental well-being is wide-ranging and varies with each person. Where some issues may require long-term psychiatric treatment and medication, other ...
Anxiety disorders are the most common mental health affliction, affecting 40 million Americans each year. Benzodiazepines are a fast-acting treatment option that can be used as needed to reduce panic, ...
The 1960s saw the initial discovery of benzodiazepines, with these widely used drugs reaching their peak around 1970 with the development of diazepam (Valium). Diazepam and its contemporaries were ...
(Reuters Health) - Even as opiate abuse has become a growing problem in the U.S., overdose deaths involving sedatives and antiseizure medications in the benzodiazepine category have also risen steeply ...
Zolpidem is a non-benzodiazepine agonist at benzodiazepine binding site in GABA A receptors, which is increasingly prescribed. Recent studies suggest that prolonged zolpidem treatment induces ...
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback